Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
503
Total raised
£3.8B
disclosed amounts
This month
£36.9M
raised so far
The pre-seed investment from LYVA Labs will accelerate product development and commercialisation.
"LYVA Labs is delighted to back Sam, Martin and Richard in their mission to help reduce the number of people dying from blood cancer by providing the technology to allow more rapid diagnosis which will enable earlier treatment for the condition."
The financing round featured backing from investors including AstraZeneca, Hitachi Ventures, and Leaps by Bayer.
"We have known Huma for several years and we’ve been impressed by their remarkable progress. We have seen this first-hand. They have demonstrated strong growth and excellent metrics. With their next-generation AI capabilities and Huma Cloud platform, Huma can partner with pharma companies to deliver efficient digital health solutions to patients focused on predictive and proactive care."
The Series D round was backed by strategic investors including AstraZeneca, HAT SGR, Hitachi Ventures, and Leaps by Bayer.
"We have known Huma for several years and we’ve been impressed by their remarkable progress. We have seen this first-hand. They have demonstrated strong growth and excellent metrics. With their next-generation AI capabilities and Huma Cloud platform, Huma can partner with pharma companies to deliver efficient digital health solutions to patients focused on predictive and proactive care."
The London-based healthtech startup secured the investment to expand its primary care automation software.
"When you work inside a GP practice every day you realise that NHS staff are in desperate need of tech that works,"
Exceptional Ventures led the pre-seed round, with participation from Bethnal Green Ventures and Angel Academe.
"We are thrilled to partner with Rebecca and Alec on PreActiv’s journey to revolutionise the prehabilitation space. Their scalable, evidence-based programmes significantly reduce surgical complications and accelerate recovery, offering a cost-effective solution to the £14 billion burden on the NHS. PreActiv’s integration of patient data, support networks, and educational resources makes it a promising innovation in improving surgical outcomes and long-term health."
